GPCR Earnings

Quarterly EPS
$-0.20
Q3 2024
$-0.21
Q4 2024
$-0.27
Q1 2025
$-0.36
Q2 2025
$-0.37
Q3 2025
$0.17
Q4 2025
$-0.35
Q1 2026
$-0.49
Q2 2026
Latest RevenueN/A
Latest Net Income-106159000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.490-106159000—-36.1%
Q1 2026-$0.350-75968000—-29.6%
Q4 2025$0.17033.0M—+181.0%
Q3 2025-$0.370-65712000—-85.0%
Q2 2025-$0.360-61661000—-100.0%
Q1 2025-$0.270-46833000—-42.1%
Q4 2024-$0.210-36479000—-16.7%
Q3 2024-$0.200-33977000—+4.8%
Q2 2024-$0.180-26034000——
Q1 2024-$0.190-26036000——
Q4 2023-$0.180-24503000——
Q3 2023-$0.210-23862000——
Structure Therapeutics Inc. American (GPCR) — Earnings